VanEck Associates’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.01M Sell
18,032
-335
-2% -$130K 0.01% 598
2025
Q1
$7.99M Buy
18,367
+3,483
+23% +$1.51M 0.01% 547
2024
Q4
$5.49M Buy
14,884
+2,102
+16% +$775K 0.01% 652
2024
Q3
$5.31M Buy
12,782
+507
+4% +$211K 0.01% 622
2024
Q2
$6.65M Buy
12,275
+411
+3% +$223K 0.01% 507
2024
Q1
$6.15M Buy
11,864
+575
+5% +$298K 0.01% 520
2023
Q4
$5.32M Buy
11,289
+245
+2% +$116K 0.01% 524
2023
Q3
$4.81M Buy
11,044
+172
+2% +$74.9K 0.01% 512
2023
Q2
$4.83M Buy
10,872
+5,629
+107% +$2.5M 0.01% 522
2023
Q1
$2.41M Buy
5,243
+359
+7% +$165K 0.01% 663
2022
Q4
$2.51M Sell
4,884
-1,476
-23% -$757K 0.01% 630
2022
Q3
$2.89M Buy
6,360
+25
+0.4% +$11.4K 0.01% 569
2022
Q2
$3.06M Buy
6,335
+71
+1% +$34.3K 0.01% 570
2022
Q1
$3.08M Sell
6,264
-1,131
-15% -$556K 0.01% 609
2021
Q4
$3.43M Sell
7,395
-41
-0.6% -$19K 0.01% 593
2021
Q3
$2.77M Buy
7,436
+642
+9% +$239K 0.01% 589
2021
Q2
$2.59M Buy
6,794
+189
+3% +$72.2K 0.01% 600
2021
Q1
$2.37M Sell
6,605
-709
-10% -$255K 0.01% 571
2020
Q4
$2.35M Buy
7,314
+1,277
+21% +$410K 0.01% 516
2020
Q3
$1.62M Sell
6,037
-6,440
-52% -$1.73M 0.01% 538
2020
Q2
$3.28M Sell
12,477
-3,908
-24% -$1.03M 0.01% 397
2020
Q1
$3.72M Sell
16,385
-2,038
-11% -$463K 0.02% 371
2019
Q4
$5.56M Buy
18,423
+725
+4% +$219K 0.02% 349
2019
Q3
$4.25M Buy
17,698
+557
+3% +$134K 0.02% 359
2019
Q2
$4.84M Buy
17,141
+1,514
+10% +$427K 0.02% 347
2019
Q1
$4.49M Buy
15,627
+12,635
+422% +$3.63M 0.02% 347
2018
Q4
$786K Buy
2,992
+102
+4% +$26.8K ﹤0.01% 575
2018
Q3
$792K Sell
2,890
-38
-1% -$10.4K ﹤0.01% 608
2018
Q2
$697K Buy
+2,928
New +$697K ﹤0.01% 623